Proceedings (Dec 2023)

Immediate Point-of-Care Testing of Breastmilk Sodium and Potassium Concentrations in Women with Mastitis

  • Emma L. Heron,
  • Ching Tat Lai,
  • Leanda J. McKenna,
  • Adelle M. McArdle,
  • Donna T. Geddes

DOI
https://doi.org/10.3390/proceedings2023093001
Journal volume & issue
Vol. 93, no. 1
p. 1

Abstract

Read online

Sodium (Na) and potassium (K) concentrations in breastmilk are often used as biomarkers to define mastitis in lactating women and can be measured with small portable point-of-care ion-selective electrodes (ISEs). The aim of this study was to test the ISEs at the point of care for accuracy and acceptability in women with mastitis. Up to 5 mL of expressed breastmilk from the affected breast of 43 women with mastitis was collected at three timepoints (day 1, 3, and 10). Immediate Na and K ISE testing was later compared to the laboratory measure of inductively coupled plasma–op-tical emission spectrometry (ICP-OES). The results revealed a statistically significant difference in Na and K concentrations between the point-of-care and laboratory testing (both p = 0.001, Wilcoxon signed-rank test); however, the difference was not statistically significant when compared for Na:K ratio (p = 0.49, Wilcoxon signed-rank test). The Bland–Altman limits of agreement were acceptable, with the majority of measurements lying within two standard deviations of the mean (Na: 94%; K: 95%; and Na:K: 96%). The testing techniques were significantly correlated for Na (R2 = 0.79, p = 0.001) and Na:K (R2 = 0.99, p = 0.001). Overall, participants rated the ISE point-of-care testing as very acceptable. In conclusion, immediate ISE point-of-care testing for breastmilk Na:K ratio in women with mastitis is clinically accurate and acceptable.

Keywords